Please login to the form below

Not currently logged in
Email:
Password:

adverse events

This page shows the latest adverse events news and features for those working in and with pharma, biotech and healthcare.

Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness

Kymriah rejected in DLBCL - but NICE wants to keep talking about cost effectiveness

The NICE committee also raised concerns about the common adverse events experienced by patients taking Kymriah. ... Most patients had severe adverse events (over grade 3), including cytokine release syndrome.

Latest news

More from news
Approximately 5 fully matching, plus 332 partially matching documents found.

Latest Intelligence

  • How pharma can unlock the potential of influencer marketing How pharma can unlock the potential of influencer marketing

    Either way, ensure you have a social playbook in place outlining who is responsible for social media monitoring and how you will respond should any adverse events or inappropriate comments occur

  • Bluebird Bio: on the cusp of a gene therapy revolution Bluebird Bio: on the cusp of a gene therapy revolution

    Conventional stem cell transplants cost anywhere between $500, 000 and $1m, while also carrying the risk of having to treat adverse events such as gvhd for example.

  • A new era of smart pharma A new era of smart pharma

    Remote monitoring has its place but sponsors must still be able to collect detailed information on clinical endpoints, serious adverse events (SAEs) and events of special interest. ... SAEs). It is in this area that pharmacovigilance, the science

  • The tipping point The tipping point

    When conditioned to expect a negative response, otherwise known as the ‘nocebo’effect, patients are more likely to report adverse events, putting a brake on biosimilar adoption.

  • Gene therapy Gene therapy

    Because of his death, 652 previously unreported, serious adverse events, including deaths, were reported to the US National Institute of Health. ... As many of these trials were performed on very sick patients, it is unclear how many of these events can

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics